Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From the CANOPY Clinical Trial

Cameron R. Wolfe, Jonathan Cohen, Kathryn Mahoney, Anna Holmes, Natalia Betancourt, Deepali Gupta, Kazima Tosh, Kristin Narayan, Ed Campanaro, Chloe Katz, Anne-Marie Phelan, Ilker Yalcin, Mark Wingertzahn, Pamela Hawn, Pete Schmidt, Yong Li, Myra Popejoy, the CANOPY Study Group
doi: https://doi.org/10.1101/2024.11.11.24317127

Article Information

doi 
https://doi.org/10.1101/2024.11.11.24317127
History 
  • November 13, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Cameron R. Wolfe1,
  2. Jonathan Cohen2,
  3. Kathryn Mahoney3,*,
  4. Anna Holmes3,
  5. Natalia Betancourt3,
  6. Deepali Gupta3,
  7. Kazima Tosh3,
  8. Kristin Narayan3,
  9. Ed Campanaro3,
  10. Chloe Katz3,*,
  11. Anne-Marie Phelan3,
  12. Ilker Yalcin3,
  13. Mark Wingertzahn3,
  14. Pamela Hawn3,#,
  15. Pete Schmidt3,*,
  16. Yong Li3,
  17. Myra Popejoy3,*,
  18. the CANOPY Study Groupa
  1. 1Duke University, Durham, North Carolina, USA
  2. 2Jadestone Clinical Research, Silver Spring, Maryland, USA
  3. 3Invivyd, Inc., Waltham, Massachusetts, USA
  1. ↵#Correspondence to
    : Pamela Hawn, phawn{at}invivyd.com
Back to top
Posted November 13, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From the CANOPY Clinical Trial
Cameron R. Wolfe, Jonathan Cohen, Kathryn Mahoney, Anna Holmes, Natalia Betancourt, Deepali Gupta, Kazima Tosh, Kristin Narayan, Ed Campanaro, Chloe Katz, Anne-Marie Phelan, Ilker Yalcin, Mark Wingertzahn, Pamela Hawn, Pete Schmidt, Yong Li, Myra Popejoy, the CANOPY Study Group
medRxiv 2024.11.11.24317127; doi: https://doi.org/10.1101/2024.11.11.24317127
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area